Search
Now showing items 1-7 of 7
Development & characterization of CpG adjuvanted SARS-CoV-2 Virus-Like Particle vaccine
(Bilkent University, 2022-06)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appeared in late 2019,
led to countless cases and deaths and eventually regarded as one of the severe pandemics
of modern times. To reduce hospitalization and ...
Large-scale manufacturing and characterization of a Sars Cov-2 virus-like particle vaccine adsorbed onto alhydrogel and adjuvanted with K3 CpG oligodeoxynucleotide for use in phase 1/2 clinical trials
(Bilkent University, 2022-04-28)
Emergence of COVID-19 pandemic has been met by an exceptionally fast response from vaccine
makers around the globe. Vaccines that elicit excellent immunological responses against SARS-CoV-2
are now widely utilized. ...
Investigation of Pre-clinical and clinical results against SARS-COV-2 wild-type and Alpha variants combination of VLP-58-1023-AL-K3 vaccine
(Bilkent University, 2022-08)
The SARS-CoV-2 virus, which first appeared in Wuhan, China and had a pandemic effect at the end of 2019, has urgently created need of suitable vaccine candidates’ development with its quick spread. Scientists in different ...
Investigation of improved immunostimulatory activity of D and K type CpG ODNs in liposomes
(Bilkent University, 2013)
CpG ODNs are potent immunotherapeutic agents. In human, two major
classes of CpG ODNs were shown to induce differential immune activation. D
ODNs are strong IFNα inducers, thus promising antiviral agents, whereas K
ODNs ...
Immunomodulatory effects of TLR ligands and polysaccharide combinations : strategies to augment innate immune response
(Bilkent University, 2007)
Microbial infection initiates multiple TLR ligand mediated signaling cascade
on innate immune cells. While some TLRs trigger a Th1 biased immune activation,
others may lead to a Th2 dominant immune response. Extracellular ...
Investigation of cellular and humoral immune responses induced by SARS-CoV-2 VLP vaccine in Pre-clinical and clinical studies
(Bilkent University, 2022-08)
COVID-19 pandemic, caused by SARS-CoV-2, emerged in China in late 2019, and as of March 2020 has become a serious concern for the whole world due to severe progression of the disease especially in the elderly and high ...
Immunoregulatory activities of nanoparticle-forming oligodeoxynucleotides
(Bilkent University, 2009)
Innate immune system is activated by a wide range of microbial by products leading to
an immediate immune activation primarily designed to neutralize and control the invading insult.
The cells of the innate immune system ...